Rochoy Michaël, Danel Antoine, Chazard Emmanuel, Gautier Sophie, Berkhout Christophe
General Practice Department, University Lille, 59000 Lille, France; Public Health Department, University Lille, CHU de Lille, ULR 2694, CERIM, 59000 Lille, France; University Lille, Inserm, CHU-Lille, Lille Neuroscience and Cognition, UMR-S1172, Degenerative and Vascular Cognitive Disorders, 59045 Lille, France.
General Practice Department, University Lille, 59000 Lille, France.
Therapie. 2022 Nov-Dec;77(6):683-691. doi: 10.1016/j.therap.2022.03.004. Epub 2022 Apr 20.
Some users of anabolic androgenic steroids (AAS) secretly consume aromatase inhibitors (AI) and selective oestrogen receptor modulators (SERM). Cyber-forums can be potential sources of information. Our aim was to determine the cycles used, and to identify the adverse drug reactions (ADRs) experienced, reported in a bodybuilding forum.
We collected discussions on a French forum for AAS users (MESO-Rx®), from January 2013 to 2019 on concerning clomiphene, tamoxifen, anastrozole, exemestane and letrozole were collected. Characteristics of the users, duration of cures, treatments, dosages, point of purchase and occurrence of ADRs were analysed.
Among the 1792 posts published on the forum, 845 concerned SERM and 571 concerned AI, i.e. 2180 drugs used (several cycles included concomitant consumption). Our population was exclusively male, with an average age of 28.2±6.3years, and had been practising weight training for 6.7±5.6years. The SERMs were mainly used to "revive the hypothalamohypophyseal axis" and the AIs to "fight against androgen aromatisation". The median treatment duration was 22 days for SERM, 70days for anastrozole, 84days for exemestane and 30days for letrozole, with a mean dose of 69mg/d for clomiphene, 22mg/d for tamoxifen, 0.4mg/d for anastrozole, 10mg/d for exemestane, 2mg/d for letrozole. The main way of obtaining these drugs was through the internet. 157 ADRs were identified: 95 for SERMs and 62 for AI. The most represented were acne, musculoskeletal, mood and reproductive disorders. Impaired quality of life (according to the patient) was described in 54% of the SERM posts and 26% of the AI posts.
Patient narratives posted on forums can be a useful tool in the context of doping, to better understand practices, motivations and possibly to bring up pharmacovigilance signals.
一些合成代谢雄激素类固醇(AAS)使用者会秘密服用芳香化酶抑制剂(AI)和选择性雌激素受体调节剂(SERM)。网络论坛可能是信息的潜在来源。我们的目的是确定在一个健身论坛中所使用的周期,并识别所经历的药物不良反应(ADR)。
我们收集了2013年1月至2019年在一个针对AAS使用者的法国论坛(MESO-Rx®)上关于克罗米芬、他莫昔芬、阿那曲唑、依西美坦和来曲唑的讨论。对使用者的特征、治疗持续时间、治疗方法、剂量、购买地点以及ADR的发生情况进行了分析。
在论坛上发布的1792个帖子中,845个涉及SERM,571个涉及AI,即使用了2180种药物(几个周期包括同时服用)。我们的研究对象均为男性,平均年龄为28.2±6.3岁,进行重量训练的时间为6.7±5.6年。SERM主要用于“恢复下丘脑-垂体轴功能”,AI主要用于“对抗雄激素芳香化”。SERM的中位治疗持续时间为22天,阿那曲唑为70天,依西美坦为84天,来曲唑为30天,克罗米芬的平均剂量为69mg/天,他莫昔芬为22mg/天,阿那曲唑为0.4mg/天,依西美坦为10mg/天,来曲唑为2mg/天。获得这些药物的主要途径是通过互联网。共识别出157例ADR:SERM相关的有95例,AI相关的有62例。最常见的是痤疮、肌肉骨骼、情绪和生殖系统紊乱。54%的SERM帖子和26%的AI帖子中描述了生活质量受损(根据患者所述)。
论坛上患者的叙述在兴奋剂使用背景下可能是一个有用的工具,有助于更好地了解用药行为、动机,并可能引发药物警戒信号。